ストックスクリーナーアプリを入手
5.89
0.68%
0.04
アフターアワーズ：
5.97
0.08
+1.36%
前日終値:
$5.85
開ける：
$5.85
24時間の取引高:
3.93M
Relative Volume:
2.20
時価総額：
$588.90M
収益：
$545.76M
当期純損益:
$-36.28M
株価収益率:
-15.69
EPS:
-0.3754
ネットキャッシュフロー:
$-25.73M
1週間 パフォーマンス:
+11.55%
1か月 パフォーマンス:
+25.85%
6か月 パフォーマンス:
+40.91%
1年 パフォーマンス:
+105.23%
1日の値動き範囲:
$5.51
$5.94
1週間の範囲:
$5.30
$6.11
52週間の値動き範囲:
$2.32
$6.11
Oncology Institute Inc Stock (TOI) Company Profile
Compare TOI vs HCA, THC, DVA, FMS, EHC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
5.89 | 588.90M | 545.76M | -36.28M | -25.73M | -0.3754 |
HCA
Hca Healthcare Inc
|
406.59 | 90.20B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
204.25 | 17.59B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
232.80 | 14.94B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
24.02 | 12.90B | 22.44B | 1.35B | 2.03B | 1.9002 |
EHC
Encompass Health Corp
|
110.16 | 10.93B | 6.07B | 793.80M | 464.40M | 5.9914 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-25 | 開始されました | Needham | Buy |
| 2025-07-23 | 開始されました | Noble Capital Markets | Outperform |
| 2025-07-16 | 開始されました | B. Riley Securities | Buy |
| 2025-05-15 | 開始されました | BTIG Research | Buy |
| 2024-02-26 | 再開されました | Jefferies | Buy |
| 2022-09-14 | 開始されました | Guggenheim | Buy |
| 2022-08-15 | 開始されました | Jefferies | Buy |
すべてを表示
Oncology Institute Inc (TOI) 最新ニュース
DFPH SEC FilingsDFP Holdings Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
The Oncology Institute (TOI) Proxy filing Summary - Quartr
TOIIW SEC FilingsThe Oncology Institute Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Oncology Institute Price Target Raised to $9.00/Share From $8.00 by BTIG - Moomoo
Oncology Institute (TOI) director receives 17,185-share fully vested RSU grant - Stock Titan
Oncology Institute (TOI) director receives 25,833 fully vested RSU shares - Stock Titan
TOI Maintained by BTIG -- Price Target Raised to $9.00 - GuruFocus
BTIG raises Oncology Institute stock price target to $9 on debt refinancing By Investing.com - Investing.com South Africa
BTIG raises Oncology Institute stock price target to $9 on debt refinancing - Investing.com Nigeria
Oncology Institute (NASDAQ: TOI) adds $75M OrbiMed loan in major refi - Stock Titan
Needham Maintains The Oncology Institute(TOI.US) With Buy Rating, Maintains Target Price $7 - Moomoo
Enterprise value to revenue forward of The Oncology Institute, Inc. – NASDAQ:TOI - TradingView
Oncology Institute refinances $86m debt with OrbiMed - Investing.com
Oncology Institute refinances $86m debt with OrbiMed By Investing.com - Investing.com India
The Oncology Institute Refinances $86 Million Debt Through OrbiMed Agreement - geneonline.com
Oncology Institute swaps $86M debt for OrbiMed financing - Stock Titan
TOI Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Market ResponseCapex Guidance - dars.gov.et
Lake Street Initiates The Oncology Institute(TOI.US) With Buy Rating, Announces Target Price $10 - Moomoo
Why Oncology Institute’s (TOI) Analyst Upgrades Put Its Community Cancer Care Growth Story in Focus - Insider Monkey
Lake Street initiates Oncology Institute stock coverage with buy rating - Investing.com UK
Lake Street initiates Oncology Institute stock coverage with buy rating By Investing.com - Investing.com South Africa
Enterprise value to EBIT forward of The Oncology Institute, Inc. – NASDAQ:TOI - TradingView
TOIOncology Institute Inc Options - Finviz
TOI Q1 2026 Earnings: Surprise EPS Beat Cuts Losses Sharply, but Revenue Remains UndisclosedSubscription Growth Report - dars.gov.et
The Oncology Institute (TOI) soars 5.3%: Is further upside left in the stock? - MSN
Enterprise value to EBITDA forward of The Oncology Institute, Inc. – NASDAQ:TOI - TradingView
Price to sales forward of The Oncology Institute, Inc. – NASDAQ:TOI - TradingView
The Oncology Institute, Inc.(NasdaqCM:TOI) added to Russell Microcap Value Benchmark Index - marketscreener.com
The Oncology Institute, Inc.(NasdaqCM: TOI) added to Russell 2000 Value Benchmark - marketscreener.com
The Oncology Institute (TOI) Soars 5.3%: Is Further Upside Left in the Stock? - Yahoo Finance
The Oncology Institute, Inc.(NasdaqCM:TOI) added to Russell Small Cap Comp Value Benchmark - marketscreener.com
The Oncology Institute, Inc.(NasdaqCM: TOI) added to Russell 2500 Value Benchmark - marketscreener.com
The Sarah Cannon Cancer Institute from HCA Healthcare Inc.quiet specialization in community oncol - Ad-hoc-news.de
Oncology Institute Inc (TOIIW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Oncology Institute Inc (TOI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Oncology Institute Inc (TOI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Insider Buying: Jorey Chernett Acquires Additional Shares of The Oncology Institute Inc (TOI) - GuruFocus
Oncology institute ten percent owner Jorey Chernett buys $90k in stock - Investing.com
Form 4 Oncology Institute Inc For: 24 June By Investing.com - Investing.com Australia
Oncology Institute (TOI) major holder Jorey Chernett buys 18,000 shares - Stock Titan
How much upside is left in the Oncology Institute (TOI)? Wall Street analysts think 38.07% - MSN
Oncology Institute Shareholders Approve Directors and Annual Say-on-Pay - The Globe and Mail
TOI News | ONCOLOGY INSTITUTE INC/THE (NASDAQ:TOI) - ChartMill
Oncology Institute (TOI) 2026 meeting backs board, auditor and annual say-on-pay - Stock Titan
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion - GlobeNewswire
Oncology Institute Inc (TOIIW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Oncology Institute Inc (TOI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Oncology Institute Inc (TOI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Oncology Institute Inc (TOI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Oncology Institute Inc (TOIIW) Institutional Confidence - TradingKey
Oncology Institute Inc (TOI) 財務データ
収益
当期純利益
現金流量
EPS
0.88%
0.24%
大文字化:
|
ボリューム (24 時間):